This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
An external barrier disease can still be life-threatening
Skin, mucus and gills protect a fish from its surrounding water. Extensive erosion compromises more than appearance: feeding, respiration and normal fluid balance can be affected. Mouth lesions may prevent feeding before a large body ulcer is obvious.
The disease can appear soon after sea transfer or following damage associated with handling. That timing should prompt investigation of both exposure and barrier injury rather than assume that every lesion was purely mechanical. Conversely, detecting bacteria on an existing wound does not automatically show which process started the problem.
Source: Marine tenacibaculosis; Tenacibaculose.
Different Tenacibaculum species matter in different settings
T. maritimum is a well-recognized cause in many marine fish, but T. dicentrarchi and T. finnmarkense also have important associations in salmonid production. Cold-water sea-phase disease in Norway differs from the simplistic picture of one warm-water organism affecting every marine farm.
Primary research in Chinook salmon supports the ability of more than one Tenacibaculum species to cause characteristic external disease. It does not establish that every environmental member of the genus is equally pathogenic. Ask whether the laboratory identified the organism sufficiently for the host and clinical question, particularly when comparing outbreaks between regions.
Source: Tenacibaculose; Experimental challenge of Chinook salmon with Tenacibaculum maritimum and Tenacibaculum dicentrarchi fulfils Koch’s postulates.
Mouth damage and skin loss should change the handling plan
Watch for reduced appetite, damaged jaws, fin erosion, visible ulcers and abnormal respiratory behavior. Yellowish surface material may be present, but color is not a unique identifier. A population can contain fish at several stages, including seriously compromised animals without the largest visible wounds.
Contact the aquatic veterinarian early. Check immediate water and oxygen conditions and avoid unnecessary crowding or procedures that create further skin damage. Moving an ulcerated fish repeatedly for a closer look adds stress without defining the organism. Fish unable to feed or swim normally need an explicit welfare assessment rather than waiting for the group’s total mortality to become dramatic.
Source: Marine tenacibaculosis; Tenacibaculose.
A wound can contain several bacteria at once
Other causes of ulceration, including Moritella-associated winter ulcers in some salmon systems, can overlap with tenacibaculosis. Mixed infections are recognized. Mechanical injury may also precede colonization, while active bacterial damage enlarges an initial small wound.
Professional examination combines lesion distribution and pathology with suitable agent identification. A positive wound test is most useful when the organism’s abundance, location and tissue effects fit. Persistent disease despite a named bacterium should prompt reassessment of coinfection, continuing injury and whether the treatment reaches the relevant site.
Source: Tenacibaculose; Experimental challenge of Chinook salmon with Tenacibaculum maritimum and Tenacibaculum dicentrarchi fulfils Koch’s postulates; Bacterial diseases in aquaculture.
Treatment can be difficult once surface damage is extensive
The clinician may consider an approved antimicrobial or other intervention after assessing susceptibility, lesion severity, appetite and the system. A response cannot be promised for every species or stage. A fish unable to eat may not receive a reliable in-feed treatment, while damaged surfaces can limit tolerance of water treatments.
Food-animal approvals and environmental conditions must guide the actual plan. Do not translate a freshwater columnaris treatment directly into seawater or use a household disinfectant on a fish wound. The practical goals include controlling active infection, stopping further skin injury and maintaining acceptable comfort and function.
Source: Marine tenacibaculosis; Bacterial diseases in aquaculture; Aquaculture and aquaculture drugs basics.
Prevention emphasizes intact skin and realistic vaccine claims
Reduce abrasion during handling, assess sea-transfer readiness and maintain rearing conditions appropriate to the host. Examine recurring outbreaks for persistent sources of injury rather than regard every ulcer as an unavoidable seasonal event. The importance of each intervention depends on the production system.
Vaccine research is active, but an investigational prototype is not the same as a broadly available, reliably protective farm product. A 2026 study of T. dicentrarchi prototypes found incomplete protection and persistent detection in survivors. This supports careful product-specific advice rather than claims that vaccination has solved all tenacibaculosis or that one treatment guarantees a clear population.
Source: Efficacy of a vaccine for Atlantic salmon using a Tenacibaculum dicentrarchi strain; Tenacibaculose; Marine tenacibaculosis.
Practical questions
Is every case caused by T. maritimum?
No. Other Tenacibaculum species are important, with regional and host differences.
Can cold seawater disease still be tenacibaculosis?
Yes. Some important salmon-associated patterns occur in cold-water sea production.
Does a positive wound test prove the bacterium initiated the wound?
Not alone. Tissue findings and the sequence of injury, colonization and active damage matter.
Related animal-health reading
Cite this reference
LivestockDefense. “Tenacibaculosis in marine fish: mouth erosion, ulcers and skin-barrier injury.” Updated 2026-11-02. https://livestockdefense.com/threats/tenacibaculosis-in-marine-fish/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- U.S. Food and Drug Administration: Aquaculture and Aquaculture Drugs Basics
Source update: Not provided. Most recent check: 2026-10-29.
FDA approves final drug products and intended uses, not active ingredients alone; no treatment authorization, drug choice or dosage inferred from a laboratory result.
- Merck Veterinary Manual: Bacterial diseases in aquaculture
Source update: 2026-06. Most recent check: 2026-11-02.
Bounded clinical distinctions among major fish bacterial diseases; no culture media, incubation, pathogen handling, drug doses or blanket extra-label-feed advice.
- Alaska Department of Fish and Game: Marine tenacibaculosis
Source update: Not provided. Most recent check: 2026-11-02.
Marine skin/gill/mouth injury and T. maritimum context; no laboratory culture or treatment protocols.
- Norwegian Veterinary Institute: Tenacibaculose
Source update: 2021-03-04. Most recent check: 2026-11-02.
Norwegian-language clinical sections inspected: T. finnmarkense/dicentrarchi, sea-phase wounds, mixed infection and skin protection; current worldwide vaccine availability not inferred from older page.
- Journal of Fish Diseases / primary research: Experimental challenge of Chinook salmon with Tenacibaculum maritimum and Tenacibaculum dicentrarchi fulfils Koch’s postulates
Source update: 2025. Most recent check: 2026-11-02.
Abstract-level host-specific causation and external lesion findings only; explicitly excludes organism growth, challenge route, concentrations, handling and experimental methods.
- Journal of Fish Diseases / primary vaccine research: Efficacy of a vaccine for Atlantic salmon using a Tenacibaculum dicentrarchi strain
Source update: 2026. Most recent check: 2026-11-02.
Abstract-level conclusion: investigational prototypes and incomplete protection/carriage, not an available proven farm vaccine; excludes production, adjuvant, exposure and dosing methods.
